William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Starts Core & Main Inc. (CNM) at Market Perform
-
William Blair Downgrades Pegasystems (PEGA) to Market Perform
-
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
-
GE Vernova misses core profit estimates as Wind weakness persists
-
Many US patients opt for obesity drug injections, defying some expectations
-
William Blair Investment Management Launches Global Leaders Select Strategy, Appoints Chandan Khanna as Co-Portfolio Manager
-
William Blair comments on Fortinet (FTNT) and Intel (INTC) strategic collaboration
-
William Blair: 'cybersecurity is now perceived as a beneficiary of AI'
-
Truelink Capital Completes Acquisition of Lyons Magnus, a Leading Developer and Manufacturer of Specialty Ingredients, Beverage, and Nutrition Solutions
-
Paine Schwartz Partners Announces Sale of Lyons Magnus to Truelink Capital
-
Reformation launches IPO on NYSE at $15-$17 per share
-
Reformation Launches Initial Public Offering
-
Reformation files for 14.06M share IPO on NYSE at $15-$17 per share
-
Greenbelt Capital Partners Invests in Bowe & Gant, a Leading Northeast Electrical and Energy Infrastructure Services Provider
-
Jersey Mike's launches IPO roadshow, targets NYSE listing as JMKE
-
Jersey Mike's Announces Launch of Initial Public Offering
-
William Blair Upgrades BJ's Restaurants (BJRI) to Outperform
-
Abbott raises 2026 profit forecast on strength in diagnostics, medical devices
-
LKCM Headwater to take Distribution Solutions Group private at $35 per share
-
Distribution Solutions Group to Be Taken Private by Affiliates of LKCM Headwater Investments for $35.00 Per Common Share in Cash
-
Standard Nuclear prices IPO at $15 per share on NYSE
-
Standard Nuclear Announces Pricing of its Initial Public Offering
-
William Blair Hires Head of Biopharma Investment Banking, based in New York
-
William Blair on Progressive Corp. (PGR): 'a likely challenging near-term environment'
-
William Blair: 'We are hesitant to chase PayPal shares higher'
-
Standard Nuclear slashes IPO plans to 10 million shares
-
William Blair: 'We think investors should stay involved in Coinbase'
-
Stripe, Advent offer to buy PayPal for more than $53 billion, sources say
-
Alto Neuroscience prices $100M stock offering to fund depression trial
-
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
-
William Blair Starts AMD (AMD) at Market Perform
-
Royer Cooper Cohen Braunfeld Advises Harbor Compliance in Majority Growth Investment from Bregal Sagemount
-
William Blair says buy the dip in this Industrial stock
-
William Blair Starts Zura Bio Ltd. (ZURA) at Outperform
-
Schmid Group issues $20M convertible notes to fund growth
-
SCHMID Group N.V. announces a USD 20 million convertible notes financing
-
William Blair Investment Management Appoints Olga Bitel as Chief Investment Strategist
-
Standard Nuclear seeks to raise up to $383.3M in US IPO
-
Standard Nuclear launches IPO roadshow targeting up to $21 per share
-
Standard Nuclear Announces Launch of its Initial Public Offering
-
William Blair Starts Arlo Technologies (ARLO) at Outperform
-
Sentinel Capital Partners Acquires DecoPac
-
William Blair Starts SpaceX (SPCX) at Outperform, 'We see share upside of greater than 20% over the next year'
-
William Blair on Glaukos Corporation (GKOS): 'We remain buyers; more so on dips'
-
Jersey Mike's files for IPO, plans NYSE listing under ticker JMKE
-
Jersey Mike's Publicly Files Registration Statement for Initial Public Offering of Class A Common Stock
-
William Blair on TransMedics Group (TMDX): 'We believe TransMedics’ second-quarter sales will exceed consensus estimates'
-
William Blair Completes Acquisition of Inner Circle Sports
-
Momentum Life Sciences Announces Strategic Growth Investment from Parthenon Capital
-
Neurogene prices $125 million public offering at $30 per share

